The AI buildout is not chip-limited. It is megawatt-limited, turbine-limited, transformer-limited, and permit-limited. Financial capital moves in months. Physical capacity takes years. The gap between those two speeds is where scarcity rents get paid — and The Scarcity Frontier is the only research system built to tell you who collects them.
You know the consensus playbook. Buy the chip designer. Buy the hyperscalers. Maybe a data center REIT if you're feeling clever. Everyone on your feed owns the same three tickers and calls it a thesis.
Here's what that playbook quietly assumes: that every announced gigawatt actually gets energized. That the turbines exist. That the transformers ship. That the interconnection queue clears. That the crews show up, the gas gets there, and the project commissions on schedule.
None of that is guaranteed. Most of it is currently the binding constraint.
When financial capital moves faster than physical capacity can respond, a rent appears. It goes to whoever controls the thing that can't be built quickly. Then, as capital floods in to relieve that bottleneck, the rent migrates to the next one down the chain.
Most investors never see the rent. They see the story, they buy the story, and they're left holding a "beneficiary of AI capex" that never had pricing power in the first place — while the company that actually owned the constraint quietly re-rated without them.
The Scarcity Frontier exists to fix that. It is not a list of AI stocks. It is a system for determining which physical constraints are genuinely binding, who controls them, whether the scarcity rent can actually reach common equity, and what evidence would confirm — or break — each investment case.
Flagship 001 is the foundational report of the Scarcity Frontier research franchise. It defines the framework, maps the constraints limiting the AI infrastructure buildout right now, and connects those constraints to publicly traded companies through detailed, falsifiable investment cases.
Every company in the report is worked the same way: the investment case, the valuation framework, the downside stress test, the catalysts, the confirmation signals, and the explicit conditions under which the thesis is wrong.
That last part is what you will not get anywhere else. Most research tells you why to buy. This tells you exactly what would make you sell — before you've put a dollar in.
Find the constraint capital can't quickly create. Track how it migrates. Map the capital response — capex, M&A, vertical integration — as revealed preference, not narrative.
Power deliverability, turbine availability, electrical equipment, skilled execution capacity, interconnection rights, bridge power, natural gas infrastructure, and project commissioning — which ones actually bind, and who controls them.
Security-level research postures across core holdings, satellite opportunities, optionality plays, and watchlist names. Catalysts, confirmation signals, and invalidation conditions for each.
Where each name sits today, what would move it, and how the pieces fit together in a portfolio — with construction guidance, not just a list.
The time dimension of every bottleneck: how long the rent lasts before new capacity shows up to compete it away — and where it goes next.
The rungs between "announced" and "energized." Evaluate any data center project by which rung it's actually on — instead of the rung the press release implies.
Why a project can have chips, land, and money and still not turn on — and why the companies that can deliver on schedule are commanding a premium the market hasn't fully priced.
A structured way to separate the pipeline that will be built from the pipeline that exists to support a stock price.
Because a valuable asset and an investable equity are not the same thing. The report separates them ruthlessly.
Serious research is expensive to produce and it's wasted on people who want a ticker to yolo. Here's the honest split.
Names where the constraint is binding, the control is durable, and the rent reaches the equity.
Real exposure, real catalysts, tighter invalidation. Sized accordingly.
Asymmetric setups where the market is pricing the narrative, not the realization.
Not yet. Here is exactly what would have to happen to change that.
Most paid research has a business model problem: it gets paid whether it's right or wrong, so it never tells you what "wrong" would look like. Then the thesis breaks, the note quietly disappears, and a new one takes its place.
The Scarcity Frontier is built the opposite way.
Every investment case ships with explicit invalidation conditions. Every thesis change is preserved in a transparent change ledger. Negative findings are published, not buried. Corrections are issued to the report — and if you bought Flagship 001, you get every one of them for free, permanently.
That is a harder way to do research. It is also the only way that produces something you can actually act on with size and sleep afterward.
Buy Flagship 001 for $395, or join Annual Research for the complete research service. Start with the report and request your upgrade within 30 days—your full $395 purchase counts toward your first year. The $999 founding rate is available to the first 100 annual members and held while continuously active. Member 101 and later pay $1,295 per year.
No. Ten companies are covered, but the report's value is the system used to evaluate them — which constraints actually bind, who controls them, whether the rent can reach the equity, and what would break each case. You'll be able to run that system on any name you find on your own.
You get permanent access to Flagship 001 plus every correction and revision issued specifically for this report. You do not get future flagships, the Research Desk, Company Maps, signals, watchlists, or quarterly briefings — those are the membership.
Ready to upgrade? Email contact@texaswestcapital.com from your member email address within 30 days of purchasing Flagship 001. We’ll verify your purchase and provide a checkout link applying your $395 credit toward your first year of Annual Research.
Credit applies to the annual price available when you upgrade. Purchasing the report does not reserve the founding rate.
Three standalone reports at $395 each would cost $1,185. The first 100 annual members pay $999 and also receive the Research Desk, Company Maps, signals, watchlists, updates, quarterly briefings, and the continuing work that keeps each thesis current.
The first 100 annual members lock in $999 per year for as long as their membership stays continuously active. Member 101 and later pay $1,295 per year. There is no monthly plan.
No. The Scarcity Frontier is independent research for informational purposes only. It is not personalized investment advice and it is not a recommendation to buy or sell any security. You are responsible for your own decisions. That's precisely why every case includes its invalidation conditions — so you can make those decisions with the full picture.
Immediately after checkout you'll have access through the TexasWest Capital member network — on the web, or via the iOS and Android apps. Start with the "Start Here" guide; it walks you through the framework, the research service, and the publishing structure.
Yes. You may cancel future renewal at any time. Payments already made are nonrefundable.
No. Flagship report purchases and Annual Research membership payments are final and nonrefundable.
The consensus already owns the story. The constraint is still available. That will not stay true for long — capital always finds the bottleneck eventually. The point is to get there first.
P.S. The founding rate isn't a marketing countdown. It's a cap. At 100 active founding members, the $999 rate closes permanently and member 101 pays $1,295 per year. If you're reading this and the button still says $999, you're early. Don't waste it.
P.P.S. Three flagship reports at the standalone price would cost $1,185. Founding Annual Research costs $999, saves $186 on the reports alone, and includes the Research Desk, Company Maps, signals, watchlists, quarterly briefings, empirical tests, and preserved thesis revisions.